GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

By Erica L. Green and Hamed Aleaziz Reporting from Washington The Trump administration on Wednesday threatened federal employees with “adverse consequences” if they fail to report on ...

(“Innate” or the “Company”) will host an event for institutional investors and analysts dedicated to its Antibody-Drug Conjugate (ADC) strategy, and particularly Nectin-4, the target of ...

None of these differences was statistically significant ... Graham, Pharm.D., FCSHP, is Drug Information Coordinator, Department of Pharmacy, Stanford Hospital & Clinics; Assistant Clinical ...

A systematic review published in Alzheimer’s and Dementia: Translational Research & Clinical Interventions looks at the association between prescribed drugs and dementia risk. Rachel Richardson, ...

Hundreds of people are being hospitalised after suffering serious adverse reaction to weight loss jabs ... over the course of six years since the drugs first began to be prescribed.

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. All day - WTI ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.